Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Fall 2021: Therapeutics III > Therapeutics of Ovarian Cancer (Weddle) > Flashcards

Therapeutics of Ovarian Cancer (Weddle) Flashcards

(42 cards)

Start Studying
1
Q

Explain the “incessant ovulation” theory.

A

That ovarian cancer risk is related to number of ovulatory cycles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List some risk factors for ovarian cancer.

A
  • early menarche, late menopause
  • increased age
  • nulliparity
  • in vitro fertilization
  • 2+ 1st degree relatives with ovarian cancer
  • BRCA1/2, p53
  • Lynch II syndrome (HNPCC)
  • Caucasian
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some factors that decrease risk of ovarian cancer?

A
  • multiple pregnancies
  • prolonged oral contraceptive use
  • prophylactic oophorectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

___________________ represents > 90% of ovarian cancer cases.

A

epithelial adenocarcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the five subtypes of ovarian cancer?

A
  • serous
  • endometrioid
  • mucinous
  • clear cell (worse prognosis)
  • sex cord stromal tumors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the current screening tool for ovarian cancer?

A

there is no effective screening tool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How should women at low risk for ovarian cancer be screened?

A

annual physical and pelvic exam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How should women at high risk for ovarian cancer be screened?

A

pelvic exam, transvaginal ultrasound, and CA-125 blood test every 6-12 months (starting age 25-35)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why do most ovarian cancer patients tend to present with advanced-stage disease?

A

because stage I and II are typically asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What symptoms may present with advanced ovarian cancer?

A
  • ascites
  • pleural effusion
  • constipation
  • small bowel obstruction
  • nausea/vomiting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is involved in a diagnostic work-up for ovarian cancer?

A
  • H&P
  • pap smear
  • transvaginal ultrasound
  • abdominal CT, chest x-ray
  • colonoscopy
  • CBC, serum chemistries, CA-125
  • exploratory laparotomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is ovarian cancer staged?

A

surgically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the standard, 1st line approach to treating ovarian cancer?

A

surgery + adjuvant therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does it mean if a patient is classified as “optimally debulked”?

A

< 1 cm of disease remaining

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does it mean if a patient is classified as “sub-optimally debulked”?

A

> 1 cm of disease remaining

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which stage of ovarian cancer does not need adjuvant chemotherapy?

A

IA/IB grade 1; just observe and follow-up every 3 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the current standard of adjuvant chemotherapy for ovarian cancer?

Study These Flashcards
A

paclitaxel and carboplatin every 3 weeks

18
Q

Elimination of carboplatin closely mirrors ___________.

19
Q

Why is the GYN/ONC cancer population extra susceptible to hypersensitivity reactions?

Study These Flashcards
A

chemotherapeutic agents used (paclitaxel, docetaxel, carboplatin, cisplatin) and exposure to multiple chemotherapy cycles

20
Q

What is a type I hypersensitivity?

Study These Flashcards
A

occurs with initial contact

21
Q

What is the mechanism of type I hypersensitivity?

Study These Flashcards
A

cross-linking to mast cells and basophils which trigger release of histamine and other inflammatory mediators

22
Q

What is a type II hypersensitivity?

Study These Flashcards
A

occurs with repeated exposure to an agent

23
Q

What is the mechanism of type II hypersensitivity?

Study These Flashcards
A

T-cells recognize antigens

24
Q

What symptoms are associated with type I hypersensitivity?

Study These Flashcards
A

anaphylaxis, itching, rash, chest tightness

25
What symptoms are associated with type II hypersensitivity?
erythema, induration (infusional type reactions)
26
Which chemo hypersensitivity culprits are actually often *infusion*-related reactions?
paclitaxel (Cremophor) and liposomal doxorubicin
27
List some common symptoms of infusion-related toxicity.
* flushing * redness * tingling * headache * shortness of breath * abdominal/chest pain
28
Most paclitaxel hypersensitivity reactions manifest as type \_\_.
I
29
What are the three standard pre-medications that can be used to avoid hypersensitivity reactions to paclitaxel?
* dexamethasone * diphenhydramine * famotidine
30
Carboplatin hypersensitivity can best be described as type IV. What is type IV?
delayed reaction occuring when antigen-sensitized cells release cytokines after subsequent contact
31
What are the two aims of intraperitoneal chemotherapy for stage IIIC ovarian cancer?
increased tumor exposure and decreased systemic toxicity
32
Patients with tumors ______ cm tend to respond best to intraperitoneal chemotherapy.
\< 2
33
What qualifications make a patient a good candidate for intraperitoneal chemotherapy?
* stage III * good performance status * normal renal function * no previous problems that could worsen during chemo (i.e., preexisting neuropathy) * no hx of bowel surgery/resection
34
What toxicities are prevalent in ovarian cancer patients treated with adjuvant bevacizumab therapy?
hypertension and GI perforations
35
Give an example of a PARP inhibitor.
olaparib, rucaparib, niraparib
36
Which PARP inhibitor should be used as maintenance after 1st line chemo for germline or somatic BRCA mutations?
olaparib (*Lynparza*)
37
Which PARP inhibitor should be used as maintenance after 1st line chemo in patients regardless of BRCA status?
niraparib (*Zejula*)
38
What are the two most common toxicities amongst all PARP inhibitors?
fatigue, anemia (also N/V)
39
What does it mean when a patient is platinum sensitive?
they have relapsed \> 6 months following completion of their initial platinum-containing regimen
40
What are the treatment options for a platinum sensitive patient?
can be treated with the initial chemo regimen again; re-use paclitaxel/carboplatin
41
What does it mean when a patient is platinum resistant?
the patient has relapsed \< 6 months after receiving a platinum-containing regimen
42
What does it mean if a patient is platinum progressive/refractory?
they have shown no response/progression of disease during primary therapy with paclitaxel/carboplatin

Fall 2021: Therapeutics III (25 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions